Abstract: A method for patterning a wafer using a phase shifting photolithography that can produce a critical symmetrical 2-dimensional structure such as a magnetic write pole of a magnetic write head. In one aspect of the invention, a photolithographic mask has an opaque portion with narrow, transparent phase shifting regions at either side of the opaque portion. A non-phase shifted region extends beyond the narrow phase shifted portion at either side of the structure. The phase shifted regions are symmetrical about the opaque region so that the image produced on the wafer is completely symmetrical. In another aspect of the invention, a phase shifted region in formed in a transparent medium with non-phase shifted regions at either side of the phase shifted region. The transition between the phase shifted region and non-phase shifted region alone defines a pattern on the wafer, without the need for an opaque structure on the mask.

Abstract: In an electronic device and method of matching an image A and an image B, grayscale centers of the image A and the image B are computed. The image A is divided into n equal parts Dk(k=1˜n) according to the grayscale center, and a grayscale density Vk of each part Dk is computed, to acquire n grayscale densities Dk(k=1˜n) which are regarded as feature data u of the image A. Feature data v of the image B are extracted in the similar way. A similarity of a grayscale density Vak selected from the feature data u and the grayscale density Vbk selected from the feature data V, is computed. Thus, n similarities are computed. A similarity ? (n, u, v) of the image A and the image B according to the n similarities.

Abstract: Disclosed herein are methods and intermediates useful in the preparation of macrolides, e.g., compounds of formula (IV) wherein R1-R12 are as defined herein.

Abstract: A method for patterning a wafer using a phase shifting photolithography that can produce a critical symmetrical 2-dimensional structure such as a magnetic write pole of a magnetic write head. In one aspect of the invention, a photolithographic mask has an opaque portion with narrow, transparent phase shifting regions at either side of the opaque portion. A non-phase shifted region extends beyond the narrow phase shifted portion at either side of the structure. The phase shifted regions are symmetrical about the opaque region so that the image produced on the wafer is completely symmetrical. In another aspect of the invention, a phase shifted region in formed in a transparent medium with non-phase shifted regions at either side of the phase shifted region. The transition between the phase shifted region and non-phase shifted region alone defines a pattern on the wafer, without the need for an opaque structure on the mask.

Abstract: A wireless access device communicates with a plurality of customer premised equipments (CPEs) via a network. The wireless access device establishes a plurality of queues and distributes intervals for each of the CPEs. The wireless access device receives packets from the network, obtains one of the intervals corresponding to one of the CPEs with a MAC address being a destination MAC address of one of the received packets, and stores each of the received packets to one of the queues with sequence number being in the obtained interval. The wireless access device transmits the received packets stored in the plurality of queues in the way of one row by one row.

Abstract: The present invention provides methods for the use of compounds having formula (I) in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, t, X, Y, Z, and n are as defined herein.

Abstract: Computer-implemented methods, systems, and computer-readable media for determining a model for predicting printability of reticle features on a wafer are provided. One method includes generating simulated images of the reticle features printed on the wafer using different generated models for a set of different values of exposure conditions. The method also includes determining one or more characteristics of the reticle features of the simulated images. In addition, the method includes comparing the one or more characteristics of the reticle features of the simulated images to one or more characteristics of the reticle features printed on the wafer using a lithography process. The method further includes selecting one of the different generated models as the model to be used for predicting the printability of the reticle features based on results of the comparing step.

Abstract: The present invention provides compositions comprising compounds having formula (I): and additionally provides methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein. In certain embodiments, the compositions are for systemic (e.g., oral) administration. In certain embodiments, methods for the treatment of various disorders including inflammatory or autoimmune disorders comprise systemically (e.g., orally) administering to a subject in need thereof a therapeutically effective amount of a compound of formula (I).

Abstract: The present invention comprises a method to diminish and/or eliminate atherosclerotic plaques, in mammals, through direct and indirect treatment of these plaques, in situ, using suitable substances which are capable of lipid removal, primarily through hydrolysis, either by a catalytic or stoichiometric process, wherein the substance targets receptors in and/or on the cell which lead to uptake into the lysosome. Such substances used to diminish and/or eliminate atherosclerotic plaques are generally comprised of lipid hydrolyzing proteins and/or polypeptides.

Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders including inflammatory or autoimmune disorders, and disorders involving malignancy or increased angiogenesis, wherein R1-R11, X, Y, Z, and n are as defined herein.

Abstract: A lamp base assembly with electronic ballast for energy-saving lamp includes a housing (22), a lamp cap (21) and an electronic ballast (24) with transistors (23) provided within the housing. A transistor heat-diffusing element surrounding each transistor is provided within the lamp base, for enhancing the heat transfer from the transistors to the housing or the lamp cap, so that the heat generated from the transistors could be transferred out of the lamp base assembly. Thus, the heat-diffusing ability of the transistors is improved, and the working temperature of the transistors could be kept within a safe scope, so that the lifetime of the energy-saving lamp is guaranteed.

Abstract: The present invention discloses an integrated dimmable compact fluorescence lamp and a circuit used therein.

Abstract: An electronic system comprises a memory, a parser, and a device driver. A plurality of applications and a document are stored in a user space of the memory, the document storing configuration parameters. The parser module parses the document to retrieve the parameters in response to invocation from at least one application. The device driver creates data structure for the parameters in the kernel space of the memory, thus to facilitate a plurality of programs to execute different functions of the system by commonly utilizing the parameters through the device driver.

Abstract: A network device for processing data packets receives data packets from networks connected to the network device, searches a rule table for data packet matching conditions corresponding to the data packets, and transmits the data packets to corresponding data packet targets. The network device further retrieves matching actions corresponding to the data packets, transmits the data packets and the corresponding matching actions to the user daemon thread module, and further transmits the data packets to corresponding daemon threads according to the corresponding matching actions.

Abstract: The signal margin of a small array 2T/2C memory is increased by writing the ferroelectric load capacitors on the bit lines to complementary states.

Abstract: A power-on reset circuit includes a first PNP transistor having an emitter, a base, and a collector coupled to ground; a second PNP transistor having an emitter coupled to the base of the first transistor, and a base and collector coupled to ground; a third PNP transistor having an emitter, a base coupled to the base of the first transistor, and a collector coupled to ground; a first resistor coupled between VDD and an internal node; a second resistor coupled between VDD and the emitter of the first transistor; a third resistor coupled between the internal node and the emitter of the third transistor; and a comparator having a first input coupled to the internal node and a second input coupled to the emitter of the first transistor for generating a power-on reset signal.

Abstract: A power-on reset circuit includes a first PNP transistor having an emitter, a base, and a collector coupled to ground; a second PNP transistor having an emitter coupled to the base of the first transistor, and a base and collector coupled to ground; a third PNP transistor having an emitter, a base coupled to the base of the first transistor, and a collector coupled to ground; a first resistor coupled between VDD and an internal node; a second resistor coupled between VDD and the emitter of the first transistor; a third resistor coupled between the internal node and the emitter of the third transistor; and a comparator having a first input coupled to the internal node and a second input coupled to the emitter of the first transistor for generating a power-on reset signal.

Abstract: The signal margin of a small array 2T/2C memory is increased by writing the ferroelectric load capacitors on the bit lines to complementary states.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R1-R3 are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.

Abstract: The present invention provides compounds, pharmaceutical compositions and methods for the treatment of specific cancers. Such compositions may generally comprise a compound of formula (I): wherein R3-R6, R8-R10, R13 and Y are as defined herein, or pharmaceutically acceptable salts or esters thereof; and a pharmaceutically acceptable carrier.